<DOC>
	<DOCNO>NCT00318682</DOCNO>
	<brief_summary>A new approach evaluation liver fibrosis propose use PULSOMETRY . The objective evaluate diagnostic performance FIBROSCAN technique , together non-invasive technique , determine able predict histological fibrosis score , define METAVIR score . This transversal study aim compare evaluation hepatic fibrosis obtain FIBROSCAN histology ( METAVIR score ) 2550 consecutive patient take charge liver biopsy . The result study compare respective performance technique prediction METAVIR score , help recommendation care patient viral hepatitis B C ; method undergo medico-economic study .</brief_summary>
	<brief_title>Evaluation Medico-Economic Study FIBROSCAN Patients With Viral Hepatitis</brief_title>
	<detailed_description>The gold standard evaluation fibrosis consider METAVIR score clinician . The result score currently use clinical decision description evolution disease . FIBROSCAN would interest avoid liver biopsy , able predict accurately METAVIR score obtain liver biopsy perform . The data available diagnostic performance FIBROSCAN incomplete , number patient study method selection ( blindness result technique ) precise . The main objective study therefore evaluate performance FIBROSCAN prediction METAVIR score &gt; 2 ( vs F0 F1 ) . An ancillary study try evaluate diagnostic performance FIBROSCAN global prediction METAVIR score . A statistical method test use reference method ordinal polytropic variable . Half sample ( 1250 patient ) use determine best THERSHOLD FIBROSCAN clinical subgroup patient , order obtain high sensibility . The second half use validation sample , threshold use estimate sensibility , specificity diagnostic parameter FIBROSCAN . The secondary objective : 1. evaluate performance FIBROSCAN prediction METAVIR score adjacent class fibrosis ( F0-F1 , F1-F2 , F2-F3 , F3-F4 ) , 2. study association elastometry fibrosis surface obtain morphometry ( consider best evaluation global liver fibrosis ) . This technique apply restricted number biopsy ( consecutive biopsy &gt; 2cm ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Viral , Human</mesh_term>
	<criteria>Chronic hepatitis B C With liver biopsy indication Patient information Drug hepatitis Metabolic hepatology Steatosis nonalcoholic steatohepatitis Autoimmune hepatopathy Noncontraindication liver biopsy Noncontraindication FIBROSCAN examination Ascites Obesity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>biopsy</keyword>
	<keyword>FIBROSCAN</keyword>
</DOC>